Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ESAB CorpESAB · Entity 3958 | President, Fab Tech | May 12, 2026 | May 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ESAB Corp
Report date May 12, 2026 · Filed May 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.001SEC Table I · non-derivative | Direct | 20,556 |
Ending reported balance
After 2026-05-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-12 · Exercise / conversion · Acquired 2,362 · Balance 21,740 F1: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Row 2 · 2026-05-12 · Tax withholding · Disposed 1,184 · Balance 20,556 F2: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2027-05-12 | Direct | 2,362 |
Reported balance
After 2026-05-12 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-12 · Exercise / conversion · Disposed 2,362 · Balance 2,362 F1: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. F3: This award represents restricted stock units that vest in three equal annual installments beginning on the third anniversary of the grant date. All remaining restricted stock units from this award will vest on May 12, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation.
F2: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability.
F3: This award represents restricted stock units that vest in three equal annual installments beginning on the third anniversary of the grant date. All remaining restricted stock units from this award will vest on May 12, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2023 Filed Feb 28, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionCommon stock, par value $0.001 | 965 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-013825 · doc4.xml · nonDerivative · entry 1 Biebuyck Olivier · CIK 0001910578 · President, Fab Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionRestricted Stock Units · Derivative | 1,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012847 · doc4.xml · derivative · entry 3 Biebuyck Olivier · CIK 0001910578 · President, Fab Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,007 Underlying: Common stock, par value $0.001 · 1,007 shares Expires 2024-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. F3 · derivative.exercise_date: These restricted stock units vested on February 22, 2023. The remaining restricted stock units will vest on February 22, 2024. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Tax withholdingCommon stock, par value $0.001 | 458 | $57.32 | $26,252.56 |
DisclosureSEC source: 0001209191-23-012847 · doc4.xml · nonDerivative · entry 2 Biebuyck Olivier · CIK 0001910578 · President, Fab Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,938 F2 · shares: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionCommon stock, par value $0.001 | 1,007 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-012847 · doc4.xml · nonDerivative · entry 1 Biebuyck Olivier · CIK 0001910578 · President, Fab Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:01 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionRestricted Stock Units · Derivative | 1,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011835 · doc4.xml · derivative · entry 3 Biebuyck Olivier · CIK 0001910578 · President, Fab Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,872 Underlying: Common stock, par value $0.001 · 1,936 shares Expires 2025-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. F3 · derivative.exercise_date: One-third of these restricted stock units vested on February 17, 2023. The remaining restricted stock units will vest in two equal annual installments on February 17, 2024 and February 17, 2025. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:01 UTC | ESAB Corp ESAB · Entity 3958 | Tax withholdingCommon stock, par value $0.001 | 978 | $58.60 | $57,310.80 |
DisclosureSEC source: 0001209191-23-011835 · doc4.xml · nonDerivative · entry 2 Biebuyck Olivier · CIK 0001910578 · President, Fab Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,389 F2 · shares: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 23:01 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionCommon stock, par value $0.001 | 1,936 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-011835 · doc4.xml · nonDerivative · entry 1 Biebuyck Olivier · CIK 0001910578 · President, Fab Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 23:00 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 3,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007145 · doc4.xml · derivative · entry 1 Biebuyck Olivier · CIK 0001910578 · President, Fab Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,696 Underlying: Common stock, par value $0.001 · 3,696 shares Expires 2026-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F2 · derivative.exercise_date: These restricted stock units vest in three equal, annual installments beginning on the first anniversary of the grant date. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 22:00 UTC | ESAB Corp ESAB · Entity 3958 | SaleCommon stock, par value $.001 | 246 | $43.62 | $10,730.52 |
DisclosureSEC source: 0001209191-22-045288 · doc4.xml · nonDerivative · entry 2 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,431 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionRestricted Stock Units · Derivative | 491 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-045288 · doc4.xml · derivative · entry 3 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock, par value $0.001 · 491 shares Expires 2022-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. F3 · derivative.exercise_date: These restricted stock units vested and became exercisable in a single installment on August 7, 2022. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionCommon stock, par value $.001 | 491 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-045288 · doc4.xml · nonDerivative · entry 1 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Read SEC document |
| July 27, 2022 Filed Jul 29, 2022 22:00 UTC Amendment | ESAB Corp ESAB · Entity 3958 | SaleCommon stock, par value $.001 | 456 | $40.70 | $18,559.20 |
DisclosureSEC source: 0001209191-22-043558 · doc4a.xml · nonDerivative · entry 2 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,186 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. F3 · shares: The original Form 4, filed on July 27, 2022, is being amended by this Form 4 amendment to correct an administrative error, which misreported 308 shares of ESAB Corporation common stock were sold pursuant to the reporting person's Rule 10b5-1 trading plan at $41.224 per share when in fact 456 shares of ESAB Corporation common stock were sold pursuant to the reporting person's Rule 10b5-1 trading plan at $40.70 per share. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person. Read SEC document |
| July 26, 2022 Filed Jul 27, 2022 22:15 UTC | ESAB Corp ESAB · Entity 3958 | SaleCommon stock, par value $.001 | 305 | $41.22 | $12,573.32 |
DisclosureSEC source: 0001209191-22-043275 · doc4.xml · nonDerivative · entry 2 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,337 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 22:15 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionRestricted Stock Units · Derivative | 911 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-043275 · doc4.xml · derivative · entry 3 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 912 Underlying: Common stock, par value $0.001 · 911 shares Expires 2023-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. F3 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments. 50% of the restricted stock units vested on July 25, 2022 and the remainder will vest on July 25, 2023. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 22:15 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionCommon stock, par value $.001 | 911 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-043275 · doc4.xml · nonDerivative · entry 1 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Read SEC document |
| July 25, 2022 Filed Jul 29, 2022 22:00 UTC Amendment | ESAB Corp ESAB · Entity 3958 | Exercise / conversionRestricted Stock Units · Derivative | 911 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-043558 · doc4a.xml · derivative · entry 3 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 912 Underlying: Common stock, par value $0.001 · 911 shares Expires 2023-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. F4 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments. 50% of the restricted stock units vested on July 25, 2022 and the remainder will vest on July 25, 2023. Read SEC document |
| July 25, 2022 Filed Jul 29, 2022 22:00 UTC Amendment | ESAB Corp ESAB · Entity 3958 | Exercise / conversionCommon stock, par value $.001 | 911 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-043558 · doc4a.xml · nonDerivative · entry 1 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:01 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Options (right to buy) · Derivative | 8,511 | $0.00 Strike: $49.40 | $0.00 |
DisclosureSEC source: 0001209191-22-029275 · doc4.xml · derivative · entry 3 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,511 Underlying: Common stock, par value $0.001 · 8,511 shares Expires 2029-05-11 F4 · derivative.exercise_date: These employee stock options vest and become exercisable in three equal, annual installments beginning on the first anniversary of the grant date. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:01 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 7,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029275 · doc4.xml · derivative · entry 2 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,085 Underlying: Common stock, par value $0.001 · 7,085 shares Expires 2027-05-12 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · derivative.exercise_date: These restricted stock units vest in three equal, annual installments beginning on the third anniversary of the grant date. Read SEC document |
| May 12, 2022 Filed May 16, 2022 22:01 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 2,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029275 · doc4.xml · derivative · entry 1 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,905 Underlying: Common stock, par value $0.001 · 2,905 shares Expires 2025-05-12 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F2 · derivative.exercise_date: These restricted stock units vest in three equal, annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 5,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 10 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,808 Underlying: Common stock, par value $0.001 · 5,808 shares Expires 2025-02-17 F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F6 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F11 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 2,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 9 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,014 Underlying: Common stock, par value $0.001 · 2,014 shares Expires 2024-02-22 F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F6 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F10 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 1,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 8 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,823 Underlying: Common stock, par value $0.001 · 1,823 shares Expires 2023-07-25 F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F6 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F9 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on July 25, 2022 and July 25, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 965 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 7 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 965 Underlying: Common stock, par value $0.001 · 965 shares Expires 2023-02-24 F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F6 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F8 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 491 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 6 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491 Underlying: Common stock, par value $0.001 · 491 shares Expires 2022-08-07 F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F6 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F7 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on August 7, 2022. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Option (right to buy) · Derivative | 7,440 | $0.00 Strike: $55.96 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 5 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,440 Underlying: Common stock, par value $0.001 · 7,440 shares Expires 2028-02-21 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F4 · derivative.exercise_date: 3,092 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Option (right to buy) · Derivative | 8,826 | $0.00 Strike: $46.94 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 4 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,826 Underlying: Common stock, par value $0.001 · 8,826 shares Expires 2027-02-23 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F3 · derivative.exercise_date: 7,334 shares of the option have already vested. The shares of the option will fully vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Option (right to buy) · Derivative | 3,809 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 3 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,809 Underlying: Common stock, par value $0.001 · 3,809 shares Expires 2026-02-24 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Option (right to buy) · Derivative | 7,182 | $0.00 Strike: $51.68 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · derivative · entry 2 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,182 Underlying: Common stock, par value $0.001 · 7,182 shares Expires 2024-05-31 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:42 UTC | ESAB Corp ESAB · Entity 3958 | GrantCommon stock, par value $0.001 | 2,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023778 · doc4.xml · nonDerivative · entry 1 Biebuyck Olivier · CIK 0001910578 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,731 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.